Transduction of human CD34+ hematopoietic progenitor cells by a retroviral vector expressing an RRE decoy inhibits human immunodeficiency virus type 1 replication in myelomonocytic cells produced in long-term culture

Journal of Virology

Volumn 70, Issue 7, 1996, Pages 4355-4360

  Bahner, Ingrid ^b   Kearns, Karen ^b   Hao, Qian Lin ^b   Smogorzewska, Elzbieta M ^b   Kohn, Donald B ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GENE PRODUCT; REV PROTEIN; STRUCTURAL PROTEIN; VIRUS PROTEIN; VIRUS VECTOR;

ARTICLE; CONTROLLED STUDY; GENE THERAPY; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; VIROGENESIS; VIRUS GENE; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

3T3 CELLS; ANIMALS; ANTIGENS, CD34; BASE SEQUENCE; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; GENE PRODUCTS, REV; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HIV CORE PROTEIN P24; HIV-1; HUMANS; MICE; MOLECULAR SEQUENCE DATA; RNA, VIRAL; T-LYMPHOCYTES; VIRUS REPLICATION;

EID: 0029992351     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.7.4352-4360.1996     Document Type: Article

References (46)

1. Bahner, I., K. Kearns, S. Coutinho, and D. B. Kohn. Unpublished data.
2. Bahner, I., C. Zhou, X.-J. Yu, Q. L. Hao, J. C. Guatelli, and D. B. Kohn. 1993. Comparison of trans-dominant inhibitory mutant human immunodeficiency virus type 1 genes expressed by retroviral vectors in human T lymphocytes. J. Virol. 67:3199-3207.
3. Bevec, D., M. Dobrovnik, J. Hauber, and E. Böhnlein. 1992. Inhibition of human immunodeficiency virus type 1 replication in human T cells by retroviral-mediated gene transfer of a dominant-negative Rev transactivator. Proc. Natl. Acad. Sci. USA 89:9870-9874.
4. Brenner, M. K., D. R. Rill, M. S. Holladay, H. E. Heslop, R. C. Moen, M. Buschle, R. A. Krance, V. M. Santanta, W. F. Anderson, and J. N. Ihle. 1993. Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 342:1134-1137.
5. Collins, L. S., and K. Dorshkind. 1987. A stromal cell line from myeloid long term bone marrow cultures can support myelopoiesis and B lymphopoiesis. J. Immunol. 138:1082-1087.
6. Cullen, B. R. 1991. Regulation of HIV-1 gene expression. FASEB J. 5:2361-2368.
7. Curiel, T. J., D. R. Cook, Y. Wang, B. H. Hahn, S. K. Ghosh, and G. S. Harrison. 1993. Long-term inhibition of clinical and laboratory human immunodeficiency virus strains in human T-cell lines containing an HIV-regulated diphtheria toxin A chain gene. Hum. Gene Ther. 4:741-747.
8. Duan, L., O. Bagasra, M. A. Laughlin, J. W. Oakes, and R. J. Pomerantz. 1994. Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single chain antibody. Proc. Natl. Acad. Sci. USA 91:5075-5079.
9. Dunbar, C. E., M. Cottler-Fox, J. A. O'Shaughnessy, S. Doren, C. Carter, R. Berenson, S. Brown, R. C. Moen, A. J. Greenblatt, F. M. Stewart, S. F. Leitman, W. H. Wilson, K. Cowan, N. S. Young, and A. W. Nienhuis. 1995. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 85:3048-3057.
10. Gilboa, E., and C. Smith. 1994. Gene therapy for infectious diseases: the AIDS model. Trends Genet. 10:139-144.
11. 10a.Hao, Q.-L., and D. B. Kohn. Unpublished observation.
12. Heaphy, S., J. T. Finch, M. J. Gait, J. Karn, and M. Singh. 1991. Human immunodeficiency virus type 1 regulator of virion expression, rev, forms nucleoprotein filaments after binding to a purine-rich "bubble" located within the rev-responsive region of viral mRNAs. Proc. Natl. Acad. Sci. USA 88:7366-7370.
13. Joshi, S., A. van Brunschot, S. Asad, I. van der Elst, S. E. Read, and A. Bernstein. 1991. Inhibition of human immunodeficiency virus type 1 multiplication by antisense and sense RNA expression. J. Virol. 65:5524-5530.
14. Kohn, D. B., K. I. Weinberg, C. Lenarsky, G. M. Crooks, L. N. Heiss, J. A. Nolta, E. M. Smogorzewska, J. Bastian, D. Wara, M. Elder, T. Bowen, M. Hershfield, R. M. Blaese, and R. Parkman. 1995. Selective accumulation of ADA gene-transduced T lymphocytes upon PEG-ADA dosage reduction after gene therapy with transduced CD34+ umbilical cord blood cells. Blood 86(Suppl. 1):1168a.
15. Kohn, D. B., K. I. Weinberg, J. A. Nolta, L. N. Heiss, C. Lenarsky, G. M. Crooks, M. E. Hanley, G. Annett, J. S. Brooks, A. El-Khoureiy, K. Lawrence, S. Wells, R. C. Moen, J. Bastian, D. E. Williams-Herman, M. Elder, D. Wara, T. Bowen, M. S. Hershfield, C. A. Mullen, M. Blaese, and R. Parkman. 1995. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat. Med. 1:1017-1026.
16. Koyanagi, Y., S. Miles, R. T. Mitsuya, J. E. Merrill, H. V. Vinters, and I. S. Y. Chen. 1987. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 236:819-822.
17. Larder, B. A., and S. D. Kemp. 1989. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). Science 246:1155-1158.
18. Lee, S. W., H. F. Gallardo, E. Gilboa, and C. Smith. 1994. Inhibition of human immunodeficiency virus type 1 in human T-cells by a potent RRE decoy comprised of the 13-nucleotide minimal Rev-binding domain. J. Virol. 68:8254-8264.
19. Lee,T. C., B. A. Sullenger, H. F. Gallardo, G. E. Ungers, and E. Gilboa. 1992. Overexpression of RRE-derived sequences inhibits HIV-1 replication in CEM cells. New Biol. 4:66-74.
20. Malim, M. H., W. W. Freimuth, J. Liu, T. J. Boyle, H. K. Lyerly, B. R. Cullen, and G. J. Nabel. 1992. Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication. J. Exp. Med. 176:1197-1201.
21. Markowitz, M., H. Mo, D. J. Kempf, D. W. Norbeck, T. N. Bhat, J. W. Erickson, and D. D. Ho. 1995. Selection analysis of human immunodeficiency virus type 1 variants with increased resistance to ABT-538. a novel protease inhibitor. J. Virol. 69:701-706.
22. Miller, A. D., and C. Buttimore. 1986. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6:2895-2902.
23. Miller, A. D., and G. J. Rosman. 1989. Improved retroviral vectors for genetransfer and expression. BioTechniques 7:980-990.
24. Miller, A. D., D. R. Trauber, and C. Buttimore. 1986. Factors involved in production of helper-free retrovirus vectors. Somatic Cell Mol. Genet. 12:175-183.
25. Moore, K. A., A. B. Deisseroth, C. L. Reading, D. E. Williams, and J. W. Belmont. 1992. Stromal support enhances cell-free retroviral vector transduction of human bone marrow long-term culture-initiating cells. Blood 79:1393-1399.
26. Morgan, R. A., K. Cornetta, and W. F. Anderson. 1990. Applications of the polymerase chain reaction in retroviral mediated gene transfer and the analysis of gene marked human TIL cells. Hum. Gene Ther. 1:135-149.
27. Nolta, J. A., and D. B. Kohn. 1990. Comparison of the effects of growth factors on retroviral vector-mediated gene transfer and the proliferate status of human hematopoietic progenitor cells. Hum. Gene Ther. 1:257-268.
28. Nolta, J. A., E. M. Smogorzewska, and D. B. Kohn. 1995. Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells. Blood 86:101-110.
29. Nolta, J. A., X. J. Yu, I. Bahner, and D. B. Kohn. 1992. Retroviral-mediated transfer of the human glucocerenrosidase gene into cultured Gaucher bone marrow. J. Clin. Invest. 90:342-348.
30. Ojwang, J. O., A. Hampel, D. J. Looney, F. Wong-Staal, and J. Rappaport. 1992. Inhibition of human immunodeficiency virus type I by a hairpin ribozyme. Proc. Natl. Acad. Sci. USA 89:10802-10806.
31. Pearson, L., J. Garcia, F. Wu, N. Modesti, J. Nelson, and R. Gaynor. 1990. A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat. Proc. Natl. Acad. Sci. USA 87:5079-5083.
32. Pomerantz, R. J., and D. Trono. 1995. Genetic therapies for HIV infections: promise for the future. AIDS 9:985-993.
33. Rhodes, A., and W. James. 1990. Inhibition of human immunodeficiency virus replication in cell culture by endogenously synthesized antisense RNA. J. Gen. Virol. 71:1965-1974.
34. Sarver, N., E. M. Cantin, P. S. Chang, J. A. Zaia, P. A. Ladne, D. A. Stephens, and J. J. Rossi. 1990. Ribozymes as potential anti-HIV-1 therapeutic agents. Science 247:1222-1225.
35. Schwartz, G. N., S. W. Kessler, S. W. Rothwell, L. M. Burrell, T. J. Reid, M. S. Meltzer, and D. G. Wright. 1994. Inhibitory effects of HIV-1 infected stromal cell layers on the production of mycloid progenitor cells in human long-term bone marrow cultures. Exp. Hematol. 22:1288-1296.
36. Su, Y., W. Popik, and P. M. Pitha. 1995. Inhibition of human immunodeficiency virus type 1 replication by a Tat-activated, transduced interferon gene: targeted expression to human immunodeficiency type 1-infected cells. J. Virol. 69:110-121.
37. Sullenger, B. A., H. F. Gallardo, G. E. Ungers, and E. Gilboa. 1990. Over- expression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell 63:601-608.
38. Szilvassy, S. J., and R. Hoffman. 1995. Enriched hematopoietic stem cells: basic biology and clinical utility. Biol. Blood Marrow Transplant. 1:3-17.
39. Trono, D., M. B. Feinberg, and D. Baltimore. 1989. HIV-1 gag mutants can dominantly interfere with the replication of the wild-type virus. Cell 59:113-120.
40. Viellard, V., E. Lauret, V. Rousseau, and E. De Maeyer. 1994. Blocking of retroviral infection at a step prior to reverse transcription in cells transformed to constitutively express interferon beta. Proc. Natl. Acad. Sci. USA 91:2689-2693.
41. Weinberg, K. I. and D. B. Kohn. 1995. Somatic gene therapy for severe combined immunodeficiency (SCID), p. 31-47. In P. L. Chang (ed.), Somatic gene therapy. CRC Press, Inc., Boca Raton, Fla.
42. Wells, S., P. Malik, M. Pensiero, D. B. Kohn, and J. A. Nolta. 1995. The presence of an autologous marrow stromal cell layer increases glucocerebrosidase gene transduction of long term culture initiating cells (LTCIC) from the bone marrow of a patient with Gaucher disease. Gene Ther. 2:512-520.
43. Woffendin, C., Z. Y. Yang, Udaykumar, L. Xu, N. S. Yang, M. J. Sheeny, and G. J. Nabel. 1994. Nonviral and viral delivery of a human immunodeficiency protective gene into primary human T cells. Proc. Natl. Acad. Sci. USA 91:11581-11585.
44. Yu, M., M. C. Leavitt, M. Maruyama, O. Yamada, D. Young, A. D. Ho, and F. Wong-Staal. 1995. Intracellular immunization of human fetal cord blood stem/progenitor cells with a ribozyme against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 92:699-703.
45. Zhou, C., I. C. Bahner, G. P. Larson, J. A. Zaia, J. J. Rossi, and D. B. Kohn. 1994. Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes. Gene 149:33-39.
46. Zhou, C., I. Bahner, J. J. Rossi, and D. B. Kohn. 1996. Expression of hammerhead ribozymes by retroviral vectors to inhibit HIV-1 replication: comparison of RNA levels and viral inhibition. Antisense Res. Dev. 6:17-24.